Myomo (MYO) Shareholder's Equity Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.86% |
| Sep 30, 2025 | 57.39% |
| Jun 30, 2025 | 82.02% |
| Mar 31, 2025 | 98.97% |
| Dec 31, 2024 | 174.93% |
| Sep 30, 2024 | -15.70% |
| Jun 30, 2024 | 9.72% |
| Mar 31, 2024 | 13.16% |
| Dec 31, 2023 | 41.36% |
| Sep 30, 2023 | 40.93% |
| Jun 30, 2023 | -14.76% |
| Mar 31, 2023 | -25.16% |
| Dec 31, 2022 | -58.73% |
| Sep 30, 2022 | -40.51% |
| Jun 30, 2022 | -25.08% |
| Mar 31, 2022 | -19.90% |
| Dec 31, 2021 | 33.24% |
| Sep 30, 2021 | 1.27% |
| Jun 30, 2021 | 37.38% |
| Mar 31, 2021 | 36.36% |
| Dec 31, 2020 | 79.98% |
| Sep 30, 2020 | 193.82% |
| Jun 30, 2020 | 42.37% |
| Mar 31, 2020 | 24.87% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | -50.63% |
| Jun 30, 2019 | -38.33% |
| Mar 31, 2019 | -32.23% |
| Dec 31, 2018 | -48.37% |
| Sep 30, 2018 | 247.48% |
| Jun 30, 2018 | 191.93% |
| Dec 31, 2017 | 171.00% |